Vincent Fisher

Vincent Fisher currently serves as the Executive Director of Global Marketing & New Product Planning at Unicycive Therapeutics, where responsibilities include leading the commercial launch planning for oxylanthanum carbonate and new product planning for UNI-494. Previously, Vincent held the position of Senior Director at Gilead Sciences, overseeing the global marketing strategies for a $14 billion antiretroviral franchise and leading the launch of products such as Genvoya and Descovy. Additional experience includes roles in marketing leadership at Advanced BioHealing, Schering-Plough Pharmaceuticals, Valeant Pharmaceuticals, Boehringer Ingelheim, and Pfizer Pharmaceuticals. Vincent holds an MBA in Marketing from the University of Phoenix, a BA in English & Marketing from the University of Missouri-Columbia, and a Certificate of Business Excellence from UC Berkeley.